1. Primary Helicobacter pylori resistance to antimicrobials in the Brussels area in 2021.
- Author
-
Miendje Deyi VY, Ntounda R, Louis H, Kahegeshe NL, Nkuize M, Burette A, Kotilea K, Gossum MV, Delhaye M, and Bontems P
- Subjects
- Humans, Metronidazole pharmacology, Drug Resistance, Multiple, Bacterial, Microbial Sensitivity Tests, Anti-Bacterial Agents pharmacology, Amoxicillin pharmacology, Clarithromycin pharmacology, Levofloxacin, Drug Resistance, Bacterial, Helicobacter pylori, Helicobacter Infections drug therapy
- Abstract
This manuscript summarizes current primary resistance of Helicobacter pylori to antibiotics in Brussels in 2021. Resistance rates were estimated at 18% for clarithromycin, 24% for levofloxacin, 52% for metronidazole, and 0% for amoxicillin and tetracycline. When compared to 2016, resistance rates remain stable, except an increase of 30% for metronidazole., Competing Interests: Declaration of competing interest None to declare., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF